treatment phase 2 negotiating some behaviour change

báo cáo khoa học: "Healthy lifestyle behaviour among Ghanaian adults in the phase of a health policy change" pdf

... Rural 32. 3 38.0 29 .7 18.6 33.4 48.0 18-19 40.0 38.8 21 .2 23.8 41.6 34.7 20 -29 37.6 37.6 24 .8 25 .1 34.7 40 .2 30-39 36.8 34.7 28 .5 23 .5 34.7 40 .2 40-49 Marital status 35.8 39 .2 24.9 ** 24 .6 32. 0 43.6 ... 82 (6.4) 669 (15.5) 595 (17.0) 1,0 52 (69.3) 810 (63.4) 3,516 (81.7) 2, 875 ( 82. 1) 408 (26 .9) 386 (30 .2) 121 (2. 8) 33 (0.9) 30 (2. 0) 48 (3.8) 21 5 (5.0) 26 2 (7.5) 1,373 (90.4) 1, 122 (87.8) 4, 028 ... 31.4 34 .2 22. 9 31.9 29 .6 30.5 *** 39.9 35.8 29 .0 *** 35.3 Poor 28 .4 33.1 38.6 26 .4 27 .9 45.6 Middle 33.0 32. 8 34 .2 32. 3 33.0 34.8 Rich 39.0 32. 5 28 .5 34.5 35.4 30 .2 Richest 38.6 37.9 23 .4 36.5...

9
408
0

ECOTOXICOLOGY: A Comprehensive Treatment - Chapter 2 pptx

Danh mục: Cao đẳng - Đại học

... Taylor & Francis, New York, 20 01 © 20 08 by Taylor & Francis Group, LLC Clements: “3357_c0 02 — 20 07/11/9 — 18 :25 — page 12 — #2 The Organismal Ecotoxicology Context 2. 1 OVERVIEW The science of ... xenobiotics (Brown et al 20 01, Hale and La Guardia 20 02, Schultz 20 03) Knowledge of the © 20 08 by Taylor & Francis Group, LLC Clements: “3357_c0 02 — 20 07/11/9 — 18 :25 — page 18 — #8 The Organismal ... Co., Inc., New York, 1973 © 20 08 by Taylor & Francis Group, LLC Clements: “3357_c0 02 — 20 07/11/9 — 18 :25 — page 21 — #11 Ecotoxicology: A Comprehensive Treatment 22 Forbes, V.E and Calow, P.,...

12
466
0

A Practical Guide to Particle Counting for Drinking Water Treatment - Chapter 2 potx

Danh mục: Cao đẳng - Đại học

... section will © 20 01 by CRC Press LLC 40 30 20 Filter Head in Feet Fliter Particle Couns Head 10 16 6: 10 :0 14 :0 18 :0 19 :5 20 :0 20 :4 20 :4 22 :0 2: 00 6: 00 10 :0 12 :2 12 :2 12 :3 13 :0 13 ... range 40 L1306/frame/pt01 Page 22 Friday, June 23 , 20 00 1:45 PM 22 45 L1306/frame/pt01 Page 23 Friday, June 23 , 20 00 1:45 PM APPLICATIONS FOR DRINKING WATER TREATMENT 23 data are properly trended ... 50.00% 40.00% 1.5 30.00% 20 .00% 0.5 10.00% 0.00% Figure 2. 2 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 Log vs percent removal © 20 01 by CRC Press LLC % Scale Log Scale 2. 5 L1306/frame/pt01...

16
493
1

DIAGNOSIS & TREATMENT - PART 2 pptx

Danh mục: Sức khỏe giới tính

... management of the solitary pulmonary nodule Am J Respir Crit Care Med 20 00;1 62( 3 Part 1):7 82 [PMID: 10988081] 42 Essentials of Diagnosis & Treatment Asthma I Essentials of Diagnosis • Episodic wheezing, ... and treatment International consensus statement American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 20 00;161 (2 Part 1):646 [PMID: 1067 321 2] Chapter ... BK: Emerging therapies for cystic fibrosis lung disease Chest 1999; 115:1 120 [PMID: 1 020 821 8] 46 Essentials of Diagnosis & Treatment Foreign Body Aspiration I Essentials of Diagnosis • Sudden onset...

54
395
0

báo cáo hóa học: " Initiation of health-behaviour change among employees participating in a web-based health risk assessment with tailored feedback" pptx

Danh mục: Hóa học - Dầu khí

... Journal of Occupational Medicine and Toxicology 20 11, 6:5 http://www.occup-med.com/content/6/1/5 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Pelletier KR: A review and analysis of ... 1.74[1.10 - 2. 74] 1.40[0.84 - 2. 32] 1.83[0.48 7. 02] 1 .29 [0.63 - 2. 63] 1.11[0.65 1.90] High CVD risk (Framingham score ≥ 20 %) 1. 82[ 0. 92 - 3.59] 2. 76[1 .29 - 5.90] 3.88[0.80 18.75] 1.83[0. 72 - 4.63] ... 1.83[0. 72 - 4.63] 1.03[0.47 2. 29] 1.63[1.13 - 2. 36] 1.56[1.03 - 2. 36] 0.89[0 .29 2. 68] 1.69[0.91 - 3.14] 1.44[0.93 2. 23] 1.76[1.00 - 3.10] 3.35[1. 72 - 6.54] 2. 57[0. 42 15.81] 1 .20 [0.45 - 3.19] 3.38[1.50...

7
538
0

Spinal Disorders: Fundamentals of Diagnosis and Treatment Part 2 potx

Danh mục: Sức khỏe người cao tuổi

... Syndromes 20 1 20 1 20 2 20 3 20 4 21 0 21 0 21 1 21 1 21 1 21 6 22 0 22 0 22 1 22 1 22 1 22 2 22 2 22 3 22 4 22 7 22 7 22 7 22 9 24 1 24 4 24 7 24 7 24 8 24 9 Acute Trauma ... References 26 1 26 1 26 2 26 2 26 3 26 5 26 5 26 7 26 7 26 8 26 8 26 8 27 1 27 1 27 2 27 3 27 3 27 5 27 5 27 6 27 7 27 8 28 0 28 0 28 0 28 0 28 1 28 1 28 2 28 3 28 4 28 5 11 Neurological Assessment in ... 29 8 29 9 29 9 301 303 303 304 304 306 306 306 311 311 3 12 313 314 319 319 320 321 321 322 324 325 326 328 329 330 330 330 331 331 3 32 3 32 3 32 333 333 334 334 335 13 Surgical...

10
445
0

Chapter 081. Principles of Cancer Treatment (Part 2) ppsx

Danh mục: Sức khỏe giới tính

... neoplasia type 2, bilateral mastectomy or oophorectomy for familial breast or ovarian cancer syndromes), or a developmental anomaly (orchiectomy in those with an undescended testis) In some cases, ... at a burden of about 109 (1 cm3) cells and kills the patient at a tumor cell burden of about 10 12 (1 kg) Efforts to treat the tumor and reduce its size can result in an increase in the growth ... growth rate Principles of Cancer Surgery Surgery is used in cancer prevention, diagnosis, staging, treatment (for both localized and metastatic disease), palliation, and rehabilitation Prophylaxis...

5
318
1

Giới thiệu RESTYLANE xóa rãnh nhăn (WRINKLES TREATMENT) (Kỳ 2) ppsx

Danh mục: Sức khỏe giới tính

...

5
140
0

Mạng thông minh và giao thức ứng dụng camel phase 2

Danh mục: Quản trị mạng

...

38
448
0

New Concepts in Diabetes and Its Treatment - part 2 docx

Danh mục: Sức khỏe giới tính

... Gliclazide Gliquidone Glimepiride Repaglinide1 1 .25 20 0.75– 12 2.5–40 80– 320 30– 120 1–8 0.5–16 1 2 1 2 1 2 1–3 1–3 1–4 16 24 12 24 12 24 10 20 6– 12 #24 4–6 Liver/kidney Liver/kidney Liver/kidney ... generation Acetohexamide Tolbutamide Chlorpropamide Tolazamide 25 0–1,500 500–3,000 100–150 100–1,000 1 2 2–3 1 2 12 18 6– 12 60 12 14 Liver/kidney Liver Kidney Liver Second generation Glibenclamide ... sensor paradigm Diabetes 1996;45 :22 3 24 1 Philipson LH, Steiner DF: Pas de deux or more: The sulfonylurea receptor and K+ channels Science 1995 ;26 8:3 72 373, 423 – 429 F Belﬁore, Institute of Internal...

27
365
0

báo cáo khoa học: " Implementing quality indicators in intensive care units: exploring barriers to and facilitators of behaviour change" pot

Danh mục: Báo cáo khoa học

... Implementation Science 20 10, 5: 52 http://www.implementationscience.com/content/5/1/ 52 18 19 20 21 22 23 24 25 26 27 28 indicators in primary care: a qualitative study Qual Health Care 20 00, 9:166-174 de Vos ... (65.5) Female 49 (34.5) 49 28 (19.7) 82 (57.7) Gender Age (years) Profession Intensivist ICU nurse 40 (28 .2) Management 20 (14.1) 12 (8.5) Teaching hospital 96 ... we use? J Crit Care 20 07, 22 :26 7 -27 4 Peters MAJ, Harmsen M, Laurant MGH, Wensing M: Room for improvement? Barriers to and facilitators for improvement in patient care 20 02 [http://www.wokresearch.nl/UserFiles/Docs/...

8
273
0

cáo khoa học: " Strengthening evaluation and implementation by specifying components of behaviour change interventions: a study protocol" pdf

Danh mục: Báo cáo khoa học

... and behaviour change methods International Journal of Obesity and Related Metabolic Disorders 20 00, 2: 131-143 22 Abraham C, Kelly M, Robert W, Michie S: Public Health Guidance on Behaviour Change ... Reviews 20 04, Issue 3, Art No.: CD00 025 9 DOI 10.10 02/ 14651858; 14 Michie S, Abraham C: Interventions to change health behaviours: evidence-based or evidence-inspired? Psychol Health 20 04, 19(1) :29 -49 ... for phases 2b and 2c and training videos for phase 2c Phase 2b: decoding/interpreting behaviour change intervention protocols (four months) This phase will generate empirical data to examine...

8
202
0

báo cáo khoa học: "The behaviour change wheel: A new method for characterising and designing behaviour change interventions" pps

Danh mục: Báo cáo khoa học

... final manuscript 20 21 22 23 Competing interests The authors declare that they have no competing interests 24 Received: January 20 11 Accepted: 23 April 20 11 Published: 23 April 20 11 25 References ... by RW and SM to classify the 24 components of the 20 10 English government tobacco control strategy [22 ] and the 21 components of the 20 06 NICE obesity guidance [23 ] The level of inter-rater agreement ... and counseling 20 06, 62( 1):89-94 doi:10.1186/1748-5908-6- 42 Cite this article as: Michie et al.: The behaviour change wheel: A new method for characterising and designing behaviour change interventions...

12
328
0

Fecal Incontinence Diagnosis and Treatment - part 2 docx

Danh mục: Sức khỏe giới tính

... ~2. 9 1.8 0.7 5 .2 4 .2 1.0 3 .2 16.0 (14.8–16.9) 3 12 P 103 P/100 M 21 8 P 6 12 P 26 98 P/3316 M 130 P ~20 2 P /20 0 M ~515 P/319 M 519 P 6 12 P 29 8 P /27 0 M e 3.9 13.1 5.1 19.0 18.3 - 7 .2 (2. 2–13.7) Summary ... (4.7–30.4) (1 .2 19.5) (7.9 23 .2) Vacuum extraction Handa et al [119] Eason et al [5] Fenner et al [138] Fornell et al [1 12] 20 01 20 02 2003 20 04 2. 3 7.4a 3.5 4 .2 (2. 2 2. 4) (1.9 28 .5) (2. 6–4.7) (1.7–10.4) ... Helwig et al [1 42] Signorello et al [104] Eason et al [5] Fenner et al [138] Christianson et al [ 120 ] 1993 20 00 20 02 2003 20 03 2. 4a 5.5 9.6a 2. 2 2. 5 (1.7–3.5) (1.8–16 .2) (3 .2 28 .5) (1.8 2. 8) (1.0–6.0)...

35
343
0

Obstructive Sleep Apnea Diagnosis and Treatment - part 2 pps

Danh mục: Sức khỏe giới tính

... Sleep Med 20 03; 21 3 21 8 21 http://www.aptweb.org/pdf/cmscpap.pdf last accessed 7-18-06 22 Flemons W, Littner MR Measuring agreement between diagnostic devices Chest 20 03; 124 :1535–15 42 23 Orr WC, ... in obstructive sleep apnea Chest 20 02; 122 :1139–1147 12 Leung RS, Bradley TD Sleep apnea and cardiovascular disease Am J Respir Crit Care Med 20 01; 164 :21 47 21 65 PMID: 11751180 13 American Academy ... spec 27 84 57 62 50 24 10 20 15 28 Prev (%) 100 (corr spec 67) 95 100 92 100 (64 corr spec) 86 95 97 95 86 89 Sens (77 corr sens) 10.6 a 25 6.5 a 0.06 0.08 0.15 0.05 0.03 a 17 0.05 0.15 0. 12 LR(L)...

47
420
0

báo cáo khoa học: "Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer" docx

Danh mục: Báo cáo khoa học

... 10 (25 .6) (2. 6) 13.0- 42. 1 0.1-13.5 10 (27 .8) (2. 8) 14 .2- 45 .2 0.1-14.5 PR (23 .1) 11.1-39.3 (25 .0) 12. 1- 42. 2 SD 20 (51.3) 34.8-67.6 19 ( 52. 8) 35.5-69.6 PD (20 .5) 9.3-36.5 (19.4) 8 .2- 36.0 NE* (2. 6) ... (38.5) 24 (61.5) Bulky Disease 37 (94.9) Present 11 (28 .2) Peritoneal (2. 6) Absent 27 (69 .2) Fallopian Tube (2. 6) Unknown ECOG Performance Status (2. 6) Ascites 32 ( 82. 1) ( 12. 8) (2. 6) NA (2. 6) FIGO ... (20 .5) ( 12. 8) 12 (30.8) 10 (25 .6) 11 (28 .2) (0.0) Leukocytosis (20 .5) (0.0) (0.0) (0.0) Febrile Neutropenia (0.0) (0.0) (5.1) (0.0) Nausea (23 .1) 20 (51.3) (15.4) (0.0) Fatigue (2. 6) 11 (28 .2) 20 (51.3)...

11
255
0

Báo cáo y học: "Specifying and reporting complex behaviour change interventions: the need for a scientific method" potx

Danh mục: Báo cáo khoa học

... Science 20 09, 4:40 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Ioannidis JPA: Contradicted and initially stronger effects in highly cited clinical research JAMA 20 05, 29 4 :21 8 -23 3 ... United States, 20 00 JAMA 20 04, 29 1: 123 8- 124 5 World Health Organisation: The World Health Report 20 02 Reducing Risks to Health, Promoting Healthy Life Geneva: World Health Organisation; 20 02 National ... Quarterly 20 04, 82: 581- 629 Sexton TL, Alexander JF: Family-Based Empirically Supported Interventions The Counseling Psychologist 20 02, 30 :23 8 -26 1 Blase KA, Fixsen DL, et al.: Residential treatment for...

6
497
0

báo cáo khoa học: " Specifying and reporting complex behaviour change interventions: the need for a scientific method" pot

Danh mục: Báo cáo khoa học

... Science 20 09, 4:40 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Ioannidis JPA: Contradicted and initially stronger effects in highly cited clinical research JAMA 20 05, 29 4 :21 8 -23 3 ... United States, 20 00 JAMA 20 04, 29 1: 123 8- 124 5 World Health Organisation: The World Health Report 20 02 Reducing Risks to Health, Promoting Healthy Life Geneva: World Health Organisation; 20 02 National ... Quarterly 20 04, 82: 581- 629 Sexton TL, Alexander JF: Family-Based Empirically Supported Interventions The Counseling Psychologist 20 02, 30 :23 8 -26 1 Blase KA, Fixsen DL, et al.: Residential treatment for...

6
447
0

BARRIER SYSTEMS for ENVIRONMENTAL CONTAMINANT CONTAINMENT and TREATMENT - PART 2 ppsx

Danh mục: Cao đẳng - Đại học

... (Fe 42+ Fe23+(OH) 12) (CO3 ⋅2H2O) GR-I (Cl–) (Fe 32+ Fe3+(OH)8Cl) GR-II (SO 42 ) (Fe 42+ Fe23+(OH) 12) (SO4⋅2H2O) Source: Liang, L., Sullivan, A.B., West, O.R., Kamolpornwijit, W and Moline, G.R., 20 03 ... illustrate these reactions are as follows: Fe0 + 6H+ + CrO 42 = Fe3+ + Cr(OH )2+ + 2H2O Fe0 +4H+ + TcO4– = Fe3+ + TcO2 + 2H2O 2Fe0 + 3UO 22+ = 2Fe3+ + 3UO2 The reduction of these metals tends to make them ... products ZVI begins to dissolve according to the following reactions: 2Fe0 + 2H2O + O2 (aq) = 2Fe2+ + 4OH– Fe0 + 2H2O = Fe2+ + H2 (aq) + 2OH– The ﬁrst reaction involves the scavenging of dissolved oxygen...

71
388
0

Handbook of industrial and hazardous wastes treatment - Part 2 pot

Danh mục: Cao đẳng - Đại học

... PCB- 124 2 (Arochlor 124 2) PCB- 125 4 (Arochlor 125 4) PCB- 122 1 (Arochlor 122 1) PCB- 123 2 (Arochlor 123 2) PCB- 124 8 (Arochlor 124 8) PCB- 126 0 (Arochlor 126 0) PCB-1016 (Arochlor 1016) Toxaphene 2, 3,7,8-Tetrachlorodibenzo-p-dioxin ... cyanide to yield cyanogen chloride: NaCN þ Cl2 À CNCl þ NaCl ! (2) NaCN þ NaOCl þ H2 O À CNCl þ 2NaOH ! 2NaCN þ Ca(OCl )2 þ 2H2 O À 2CNCl þ Ca(OH )2 þ 2NaOH ! (3) (4) These reactions are not dependent ... sulﬁte 3SO2 þ 3H2 O À 3H2 SO3 ! (13) Sulﬁte ions are oxidized by the half reaction: ! SO3 2 þ H2 O À 2eÀ þ 2Hþ þ SO4 2 Copyright #20 04 by Marcel Dekker, Inc All Rights Reserved (14) Treatment...

264
958
0